Home » Topics » Regulatory » Patents

Patents
RSS

COX-2 inhibitors claimed by Searle

May 17, 1996

Triazole antifungals reported by Tanabe

May 17, 1996

Takeda reports oral cephem antibacterials

May 17, 1996

Kappa-opioid agonists reported by Pfizer

May 17, 1996

Allergan claims retinoid-like compounds for dermatologic indications

May 17, 1996

Pfizer claims analgesic bradykinin antagonists

May 17, 1996

Sandoz synthesizes new antidiabetic agents

May 10, 1996

Potential pancreatitis treatments reported by Snow Brand

May 10, 1996

Taisho research into fibrinogen antagonists

May 10, 1996

More Na+/H+-exchange inhibitors from Hoechst

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.